Smoking, postmenopausal hormone therapy and the risk of venous thrombosis: a population-based, case-control study.
Department of Epidemiology, University of Washington, Seattle, WA, USA; Department of Medicine, Geneva University Hospitals, Geneva, Switzerland. blondm@uw.edu, marc.blondon@hcuge.ch.
Marc
M
Blondon
Kerri L
KL
Wiggins
Astrid
A
Van Hylckama Vlieg
Barbara
B
McKnight
Bruce M
BM
Psaty
Kenneth M
KM
Rice
Susan R
SR
Heckbert
Nicholas L
NL
Smith
D000368:Aged; D016022:Case-Control Studies; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects / Q000627:therapeutic use; D042724:Estrogens, Esterified (USP) / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects* / Q000706:statistics & numerical data; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects / Q000627:therapeutic use; D008955:Models, Cardiovascular; D017698:Postmenopause / Q000097:blood; D012306:Risk; D012907:Smoking / Q000009:adverse effects* / Q000453:epidemiology; D019851:Thrombophilia / Q000139:chemically induced / Q000209:etiology*; D020246:Venous Thrombosis / Q000453:epidemiology* / Q000209:etiology; D014861:Washington / Q000453:epidemiology
D004966:Estrogens, Conjugated (USP); D042724:Estrogens, Esterified (USP); D017258:Medroxyprogesterone Acetate
hormone therapy; interaction; menopause; smoking; venous thrombosis